Limerick, Ireland, June 26, 2025 (Globe Newswire) – Kneat.com, inc. (TSX: KSI) (OTCQC: Ksiof)A leader in the validation and quality of scanning and automation quality processes is pleased to announce that a health and health diagnostic technology (“The Company”) has signed a multi -year control service agreement with Kneat.
The company, whose headquarters are in the United States, employs more than 50,000 people and manufactures in more than a dozen countries around the world. This manufacturer of medical technologies, including medical devices and pharmaceutical diagnoses, will initially use the Kneat GX platform to digitize its workflows for commissioning, qualification and validation for installations, equipment and IT systems in several lead manufacturing sites.
“After an in -depth evaluation process, this world leader has selected Kneat to stimulate efficiency, quality and conformity thanks to greater digitization of their validation processes,” said Eddie Ryan, CEO of Kneat. “I am happy that Kneat supports both new versions and current operations where we are proven to offer significant commercial value.”
The constant rhythm of the strategic victories of the Kneat client indicates that digital validation is gradually becoming the standard for life sciences. The State of Validation 2025 study also supports this trend. The total percentage of organizations interviewed which use or plan to use digital validation is now 93%, compared to 86% in the 2024 study. The change is not surprising. Well done, digital validation offers speed to the market; Reliable and scalable conformity; And a base aimed at taking advantage of integrated automation and IA -focused innovations in the future.
About the Kneat
Kneat Solutions offers the main companies in highly regulated industries an unequaled efficiency of validation and compliance thanks to its Kneat GX digital validation platform. As a leader in industry in customer satisfaction, Kneat has an excellent implementation record, fueled by our friendly design, our expert support and our on -demand training academy. Kneat GX is a advanced digital validation platform that allows highly regulated businesses to manage any end-to-end validation discipline. Kneat GX is fully compliant ISO 9001 and ISO 27001, fully validated and 21 CFR part 11 / Annex 11. Several independent customer studies have a reduction of 40% of documentation cycle time, up to 20% faster speed on the market and a higher compliance standard.
Edifying and prospective statements
With the exception of historical facts contained in the presentations, certain information presented constitutes “prospective information” within the meaning of the applicable Canadian laws. This prospective information includes, but without limiting themselves, the relationship between Kneat and the Customer, the Kneat commercial development activities, the time for use and implementation of the Kneat software in customer validation processes, the customer’s capacity and intention to develop the Kneat software in the customer organization, and the compliance of the Kneat platform under regulation and inspection. Although such prospective declarations are expressed by the Kneat, as indicated in this press release, in good faith and believed by the Kneat as having a reasonable basis, they are subject to important risks and uncertainties. Following these risks and uncertainty, predicted events in these prospective declarations may differ significantly from real results or events. These prospective declarations are not future performance guarantees, since they include risks and uncertainties.
Kneat does not undertake any obligation to publish public revisions to a prospective declaration, unless this may be required under applicable securities laws. Investors should not assume that any lack of update to a previously published prospective declaration constitutes a reaffirmation of this declaration. Continuous dependence on prospective declarations is at risk of an investor.
For more information, visit www.kneat.com.
Contact:
Katie Keita, Kneat investor relations
P: + 1 902-450-2660
E: Investors @kneat.com
